1. Home
  2. PSIX vs ANIP Comparison

PSIX vs ANIP Comparison

Compare PSIX & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PSIX

Power Solutions International Inc.

HOLD

Current Price

$86.27

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$76.02

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSIX
ANIP
Founded
1985
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PSIX
ANIP
Price
$86.27
$76.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$98.76
$107.33
AVG Volume (30 Days)
407.9K
459.0K
Earning Date
03-13-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
122.27
N/A
EPS
5.26
1.67
Revenue
$675,481,000.00
$826,880,000.00
Revenue This Year
$50.35
$44.19
Revenue Next Year
$20.10
$11.25
P/E Ratio
$15.88
$47.71
Revenue Growth
54.78
48.87
52 Week Low
$18.10
$54.10
52 Week High
$121.78
$99.50

Technical Indicators

Market Signals
Indicator
PSIX
ANIP
Relative Strength Index (RSI) 62.31 35.03
Support Level $65.96 $78.38
Resistance Level $87.50 $83.80
Average True Range (ATR) 6.44 2.77
MACD 0.94 -0.45
Stochastic Oscillator 93.33 0.10

Price Performance

Historical Comparison
PSIX
ANIP

About PSIX Power Solutions International Inc.

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: